|
|
Novabay Pharmaceuticals Inc (NYSE: NBY) |
|
|
|
| |
Novabay Pharmaceuticals Inc 's Revenue per Employee
Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales
Novabay Pharmaceuticals Inc 's Revenue per employee fell on a trailing twelve month basis to $ 305,839, but the productivity of Novabay Pharmaceuticals Inc 's employees remained above the company average. Within the Healthcare sector Employees of 317 other companies have achieved higher revenue per employee. While Novabay Pharmaceuticals Inc 's total ranking has deteriorated compared to the previous quarter from 1849 to 2469. Novabay Pharmaceuticals Inc has 31 employees.
What is Sales per Employee Ratio?
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| NBY Revenue per Employee |
(Dec 31 2024)
IV. Quarter |
(Sep 30 2024)
III. Quarter |
(Jun 30 2024)
II. Quarter |
(Mar 31 2024)
I. Quarter |
(Dec 31 2023)
IV. Quarter |
| Y / Y Revenue Change |
-40.49 % |
-13.99 % |
-44.26 % |
-38.54 % |
0.03 % |
| Sales per Employee (TTM) $ |
305,839 |
349,935 |
362,742 |
424,226 |
477,452 |
| NBY's Total
Ranking |
# 2469 |
# 1849 |
# 0 |
# 0 |
# 0 |
| Seq. Revenue Change |
-17.7 % |
1.71 % |
-8.78 % |
-22.07 % |
18.96 % |
| Revenue per Employee Statistics |
| High |
Average |
Low |
| $ 588,065 |
$ 275,003 |
$ -66,290 |
| (Dec 31 2017) |
|
(Sep. 30, 2014) |
Date modified: 2025-04-03T14:08:22+00:00
| Companies with similar Revenue per Employee for 12 months ending Dec 31 2024, within Healthcare Sector | Revenue per Employee | Revenue 12 months ending Dec 31 2024 | Number of Employees Dec 31 2024 | | Immucell Corp | 529,863.38 | $ 26.493 Million | 50 | | Harrow Inc | 521,908.38 | $ 199.369 Million | 382 | | Caredx Inc | 519,105.75 | $ 333.785 Million | 643 | | Natera Inc | 515,308.53 | $ 1,696.911 Million | 3,293 | | Tela Bio Inc | 514,947.37 | $ 68.488 Million | 133 | | Prophase Labs Inc | 510,750.00 | $ 12.258 Million | 24 | | Enanta Pharmaceuticals Inc | 508,328.24 | $ 66.591 Million | 131 | | Veracyte Inc | 505,699.39 | $ 412.145 Million | 815 | | Xtant Medical Holdings Inc | 505,241.38 | $ 117.216 Million | 232 | | Globus Medical Inc | 503,871.00 | $ 2,519.355 Million | 5,000 | | Avantor Inc | 502,488.89 | $ 6,783.600 Million | 13,500 | | Puma Biotechnology Inc | 501,017.39 | $ 230.468 Million | 460 | | Milestone Scientific Inc | 496,152.24 | $ 8.435 Million | 17 | | Sanofi | 495,997.20 | $ 49,599.720 Million | 100,000 | | Iradimed Corporation | 494,879.20 | $ 73.242 Million | 148 | | Cadre Holdings inc | 492,626.74 | $ 567.506 Million | 1,152 | | Scilex Holding Company | 492,086.96 | $ 56.590 Million | 115 | | Resmed Inc | 490,561.42 | $ 4,895.803 Million | 9,980 | | Neuropace Inc | 488,179.01 | $ 79.085 Million | 162 | | Si bone inc | 485,816.86 | $ 167.121 Million | 344 | | 10x Genomics Inc | 484,894.36 | $ 610.482 Million | 1,259 | | Intellia Therapeutics Inc | 482,308.33 | $ 57.877 Million | 120 | | Elanco Animal Health Incorporated | 477,311.83 | $ 4,439.000 Million | 9,300 | | The Oncology Institute Inc | 476,863.03 | $ 393.412 Million | 825 | | Bausch Health Companies Inc | 474,839.66 | $ 9,625.000 Million | 20,270 | | Illumina Inc | 472,648.65 | $ 4,372.000 Million | 9,250 | | Emmaus Life Sciences Inc | 470,057.14 | $ 16.452 Million | 35 | | Nurix Therapeutics Inc | 466,230.77 | $ 54.549 Million | 117 | | Hologic Inc | 461,800.93 | $ 3,261.700 Million | 7,063 | | Alpha Pro Tech Ltd | 459,137.10 | $ 56.933 Million | 124 |
|
